Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential. Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential. Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential. Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy
EF launches search for strategic partner in bid to become world’s best cycling team
Additional investment builds on EF’s existing commitment and will go towards building Tour de France Femmes winning squad and long-term talent development on men’s and
CGTN: Beyond differences: Why the British PM calls long-awaited China trip a ‘huge opportunity’
CGTN published an article on UK Prime Minister Keir Starmer’s visit to China, highlighting that amid rising global uncertainty, Beijing and London are placing greater
Bodor Laser Introduces the “Extreme Speed” Concept in Tube Processing, Launches the SK Series High-Speed Tube Laser Cutting Machine
JINAN, China, Jan. 29, 2026 (GLOBE NEWSWIRE) — Bodor Laser, a global manufacturer of laser cutting solutions, has announced the launch of its SK Series